Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie R Nicol

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|February 1, 2021
Treating viruses in the brain: Perspectives from NeuroAIDSMelanie R Nicol, MaryPeace McRae
AIDS Research and Human Retroviruses|September 13, 2022
Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in WomenAlyssa M Lantz, Melanie R Nicol
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2025
Hormones, microbes, and PrEP drugs in the female genital tractMelanie R Nicol, Christopher M Olsem
AIDS (London, England)|August 29, 2024
Deconvoluting the contribution of antiretroviral choice in weight gainMelanie R Nicol, Halima Dawood, Jennifer F Hoy
The Journal of Antimicrobial Chemotherapy|March 24, 2026
Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention modelLindsey B Collins, An Le, Melanie R Nicol
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2020
Reply to NevesMelanie R Nicol, David R Boulware, Radha Rajasingham
Pharmacotherapy|March 1, 2019
Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United StatesJessica L Adams, Karishma Shelley, Melanie R Nicol
Clinical Investigation|January 11, 2014
HIV PrEP Trials: The Road to SuccessMelanie R Nicol, Jessica L Adams, Angela Dm Kashuba
Journal of Clinical Pharmacology|June 15, 2018
Pharmacology of Antiretrovirals in the Female Genital Tract for HIV PreventionMelanie R Nicol, Joseph A Corbino, Mackenzie L Cottrell
NPJ Genomic Medicine|September 1, 2020
Pharmacogenomics of COVID-19 therapiesTakuto Takahashi, Jasmine A Luzum, Melanie R Nicol, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|February 1, 2021
Treating viruses in the brain: Perspectives from NeuroAIDSMelanie R Nicol, MaryPeace McRae
AIDS Research and Human Retroviruses|September 13, 2022
Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in WomenAlyssa M Lantz, Melanie R Nicol
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2025
Hormones, microbes, and PrEP drugs in the female genital tractMelanie R Nicol, Christopher M Olsem
AIDS (London, England)|August 29, 2024
Deconvoluting the contribution of antiretroviral choice in weight gainMelanie R Nicol, Halima Dawood, Jennifer F Hoy
The Journal of Antimicrobial Chemotherapy|March 24, 2026
Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention modelLindsey B Collins, An Le, Melanie R Nicol
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2020
Reply to NevesMelanie R Nicol, David R Boulware, Radha Rajasingham
Pharmacotherapy|March 1, 2019
Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United StatesJessica L Adams, Karishma Shelley, Melanie R Nicol
Clinical Investigation|January 11, 2014
HIV PrEP Trials: The Road to SuccessMelanie R Nicol, Jessica L Adams, Angela Dm Kashuba
Journal of Clinical Pharmacology|June 15, 2018
Pharmacology of Antiretrovirals in the Female Genital Tract for HIV PreventionMelanie R Nicol, Joseph A Corbino, Mackenzie L Cottrell
NPJ Genomic Medicine|September 1, 2020
Pharmacogenomics of COVID-19 therapiesTakuto Takahashi, Jasmine A Luzum, Melanie R Nicol, et al.
Pageof 6